Search clinical trials for: Coronary Stent System

Total 255829 results

Jeil Pharmaceutical Co., Ltd.

Completed

Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent

ANEURYSM CORONARY ARTERY
Boston Scientific Corporation

Completed

A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent

Coronary Artery Disease

Italy
National University, Singapore
Boston Scientific Corporation

Completed

Sleep and Stent Study: a Multicentre, Prospective Study

Obstructive Sleep Apnea

Singapore
CHEOL WHAN LEE, M.D., Ph.D
Medtronic; CardioVascular Research Foundation, Korea; Chong Kun Dang Pharmaceutical...

Terminated

Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation (STAMP-DES)

Coronary Artery Disease

Korea, Republic of
IHF GmbH - Institut für Herzinfarktforschung
OrbusNeich

Withdrawn

COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials (COSTA)

Coronary Disease | Stable Angina | Unstable Angina | STEMI | NSTEMI

Germany
Gangnam Severance Hospital

Completed

Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents (OPTIMA-C)

Ischemic Heart Disease
Thorax Centrum Twente

Unknown

DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity (DUTCHPEERS)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands
Thorax Centrum Twente

Unknown

Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents (BIONYX)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands, Israel, Belgium
Boston Scientific Corporation

Completed

Comparative Registry of the PROmus™, ENdeavor™ and CYpher™ Drug Eluting Stents (ProEnCy)

Percutaneous Coronary Intervention

Germany
Boston Scientific Corporation

Completed

Non-inferiority Trial to Assess the Safety and Performance of the Evolution Coronary Stent (Evolve)

Coronary Artery Disease

Spain, Belgium, France, Australia, United Kingdom, Sweden, New Zealand, Denmark, Poland
Boston Scientific Corporation
Pharmaceutical Research Associates

Completed

TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study (TE-Prove) (TE-Prove)

Coronary Heart Disease

Spain, Belgium, Latvia, United Kingdom, Germany, France, Ireland, Italy, Poland, Hungary
Boston Scientific Corporation
Pharmaceutical Research Associates; Medidata Solutions

Completed

PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study (PE-Prove)

Coronary Heart Disease

Spain, Ireland, Denmark, United Kingdom, Belgium, Germany, France, Netherlands, Italy, Austria, Hungary
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus (ESSENCE-DM)

Coronary Artery Disease

Korea, Republic of
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial

Coronary Artery Disease

China
Deutsches Herzzentrum Muenchen
Biotronik AG

Completed

Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4 (ISAR-DESIRE 4)

Acute Coronary Syndrome | Stable Angina Pectoris | Restenosis

Germany
Yonsei University

Completed

Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent Implantation (ABCD)

Coronary Artery Disease

Korea, Republic of
Biotronik AG

Completed

Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis. (BIOLUX-RCT)

Coronary Artery Disease | Coronary Restenosis

Germany, Latvia
Qvanteq AG
Cardialysis BV

Completed

Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation

Coronary Artery Disease

Netherlands, Switzerland
Deutsches Herzzentrum Muenchen

Unknown

Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation (ISAR-TRIPLE)

Coronary Artery Disease | Atrial Fibrillation

Denmark, Germany
Abbott Medical Devices

Completed

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Occlusion | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis | Thrombosis (Stent Thrombosis)

China
Teikyo University

Unknown

3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation (MODEL U-SES)

Coronary Artery Disease

Japan
Seoul National University Hospital
Abbott

Unknown

Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerosis (HOST-ALPINE)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Percutaneous Coronary Intervention

Korea, Republic of
Yonsei University

Completed

Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents

Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension

Korea, Republic of
North Texas Veterans Healthcare System

Terminated

Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT) (STRUT-OCT)

Optical Coherence Tomography (OCT) | Percutaneous Coronary Intervention (PCI) | Drug Eluting Stents (DES) | Uncovered and Malapposed Stent Struts

United States
Abbott Medical Devices

Completed

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Thailand, Israel, Spain, Italy, United Kingdom, Malaysia, Austria, France, Germany, Poland
Medtronic Vascular

Completed

RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia (R-A)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Coronary Stenosis

India
Elpen Pharmaceutical Co. Inc.

Completed

Antiplatelet Therapy Following Stent Implantation (Anti-Clot)

Angina, Unstable | Acute Myocardial Infarction | Coronary Syndrome

Greece
Meshalkin Research Institute of Pathology of Circulation

Completed

Stress-MRI Assessment After Right Coronary Artery CTO Recanalization

Coronary Artery Disease | Ischemic Heart Disease | Coronary Atherosclerosis | Coronary Artery Stenosis

Russian Federation
Meshalkin Research Institute of Pathology of Circulation

Completed

T-provisional Stenting vs Mini-Crush in Chronic Total Occlusions (CTO)

Coronary Artery Disease | Ischemic Heart Disease | Coronary Atherosclerosis | Coronary Artery Stenosis

Russian Federation
Palmaz Scientific
ClinLogix. LLC

Completed

Evaluation of the Palmaz Mach-5 Grooved Bare Metal Coronary Stent System Versus the Palmaz Bare Metal Coronary Stent System in Patients With Symptomatic Ischemic Heart Disease: A Safety and Performance Study

Ischemic Heart Disease
Seoul National University Bundang Hospital
Korea University; Inje University; SMG-SNU Boramae Medical Center; Kyung Hee University... and other collaborators

Completed

Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent (ORIENT)

Coronary Artery Disease | Coronary Heart Disease | Stable Angina | ST-segment Elevation Myocardial Infarction | Unstable Angina | Non-ST-segment Elevation Myocardial Infarction

Korea, Republic of
Medtronic Vascular

Completed

Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease

China
Sino Medical Sciences Technology Inc.

Completed

BuMA OCT Study(A Comparative Evaluation of the Extent of Neointima Formation at 3 Months After Implantation Using OCT)

Coronary Heart Disease | Stable Angina Pectoris | Unstable Angina Pectoris | Silent Myocardial Ischemia

China
Boston Scientific Corporation

Completed

ION US Post-Approval Study

Coronary Artery Disease | Atherosclerosis

United States
Biotronik AG

Completed

Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice (ENERGY)

De Novo and Re-stenosed Coronary Artery Lesions

Switzerland, Netherlands, Israel, Spain, Latvia, Germany, Austria, Belgium, France, Ireland
Atrium Medical Corporation

Terminated

The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries (VANTAGE-1)

Coronary Artery Disease

New Zealand
Cook Group Incorporated

Terminated

Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery

Coronary Artery Disease

Germany
Maasstad Hospital

Completed

A Trial of Everolimus-eluting Stents and Paclitaxel-eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (COMPARE 1)

Acute Coronary Syndrome | Stable Angina | Unstable Angina

Netherlands
Ajou University School of Medicine
B. Braun Korea Co., Ltd.

Unknown

ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)

Stable Angina, Unstable Angina, Silent Coronary Ischemia, Coronary Artery Disease

Korea, Republic of
Shanghai Jiao Tong University School of Medicine

Completed

Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions (RESOLUTE-DM)

Coronary Artery Disease | Diabetes

China
Seung-Jung Park
Otsuka Pharmaceutical Development & Commercialization, Inc.

Terminated

Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)

Coronary Artery Disease

Korea, Republic of
A.O. Ospedale Papa Giovanni XXIII
Light Lab Imaging, Inc.

Completed

Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial (OCTAVIA)

Acute Myocardial Infarction
European Society of Anaesthesiology
Erasmus Medical Center; University of Leeds

Completed

Occurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac Surgery (OBTAIN)

Thrombosis | Bleeding | Cardiac Events

Germany, Netherlands, United Kingdom
Hamilton Health Sciences Corporation
University Health Network, Toronto; McMaster University; London Health Sciences...

Completed

Association Between Perioperative Platelet Function and Major Adverse Perioperative Events

Surgery

Canada
Biosensors Europe SA
European Cardiovascular Research Center

Unknown

A Randomized Clinical Evaluation of the BioFreedom™ Stent (Leaders Free)

Bleeding | Stable Angina | In-stent Coronary Artery Restenosis | Ischemic Heart Disease Silent | ST Elevation (STEMI) and Non-ST Elevation (NSTEMI) Myocardial Infarction

Switzerland
Abbott Medical Devices

Completed

A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population (SV JAPAN)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis

Japan
Barts & The London NHS Trust
Medtronic

Completed

Comparison of Two New Generation Drug Eluting Stents in Patients With Diabetes (OCT-DES) (OCT-DES)

Coronary Artery Disease | Diabetes

United Kingdom
Boston Scientific Corporation
Eli Lilly and Company; Daiichi Sankyo, Inc.

Completed

TAXUS Libertē Post Approval Study

Coronary Artery Disease

United States
Foundation of Cardiovascular Research and Education...

Completed

DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population (DUTCH PEERS)

Myocardial Infarction | Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Angina, Unstable | Coronary Stenosis | Coronary Restenosis

Netherlands
Foundation of Cardiovascular Research and Education...

Completed

The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente (TWENTE)

Coronary Artery Disease | Angina Pectoris | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands

Search clinical trials for: Coronary Stent System

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations